[1]
Wadieh, D. and Ilie, P.C. 2025. Efficacy and safety profile of TULA for recurrent non-muscle-invasive bladder cancer among urology outpatients at an NHS district general hospital. Atena Journal of Urology . 5, (Dec. 2025), 1.